Bio-Rad Receives the US FDA’s Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19

Shots:

• The US FDA has granted EUA for its COVID-19 Droplet Digital PCR (ddPCR) test that runs on Bio-Rad’s QX200 and QXDx ddPCR systems
• Due to its high sensitivity, the test is well-suited for screening upper respiratory samples in patients with a low viral load as compared to other quantitative PCR tests. The test provides clinicians with a high degree of sensitivity to improve the accuracy of reported results
• The EUA marks the Bio-Rad’s second EUA that has been granted for COVID-19. On Apr 30, 2020, the company has received EUA for its serology test to detect AB to the COVID-19

Click here ­to­ read full press release/ article | Ref: Bio-Rad | Image: Bio-Rad